TheraSource has developed novel recombinant proteins and peptides to treat inflammatory diseases including acute kidney injury (AKI), inflammatory bowel disease (IBD), acute ischemic stroke, acute radiation syndrome, sepsis and shock.
Discovering novel therapeutics for inflammatory diseases